The MURAB project has the ambition to drastically improve precision and effectiveness of the biopsy gathering for cancer diagnostic operations. By reducing the usage of expensive Magnetic Resonance Imaging (MRI) to a minimum in the workflow and at the same time yield the same precision during samples targeting, a new workflow will be offered to the practice. Guided by a novel MRI-Ultrasound (US) registration, a robotically steered US transducer equipped with an acoustically transparent force sensing will autonomously scan the target area and optimally acquire volumetric and elastographic data. An innovative technique, called Tissue Active Slam (TAS), will be developed in the project to optimally register the intraoperational acquired volume to the preoperational MR image

Read more about MURAB


MURAB featured by the EU Commission

MURAB project is featured in these communications by the European Commission about robotics, health and Artificial Intelligence. We are proud to see that our research has reached this level of diffusion and hope that its results will be useful to all EU citizens.   European Commission launches EU-wide public consultation on Europe’s Beating Cancer Plan […]

Read more about MURAB featured by the EU Commission